Across TCGA pan-cancer cohorts, RNU6-1071P RNA is linked to patient survival in 1 of 34 cancer types, making it the most broadly survival-associated RNU6-1071P data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNU6-1071P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1071P expression acts as an unfavorable survival marker.

OV are the cancer types where RNU6-1071P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	IV	0.007	0.760	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 1 strongest of 1 lineages.

Exploration

Same gene, other analysis: RNU6-1071P tumor-vs-normal RNA expression · all RNU6-1071P data types